HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Oxprenolol

HCID 4631
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
6452-71-7
Standard SMILES
C=CCOc1ccccc1OCC(O)CNC(C)C
InChIKey
CEMAWMOMDPGJMB-UHFFFAOYSA-N
Molecular formula
C15H23NO3
Average molar mass
265.35 g/mol
Monoisotopic mass
265.1677936

Overview

1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)-2-propanol is an aromatic ether.

Names & identifiers

Preferred name
Oxprenolol
IUPAC
1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol
English name
oxprenolol
Molecular formula
C15H23NO3
Molecular weight
265.35

Names & synonyms

oxprenolol6452-71-7CoretalOxprenololum519MXN9YZRDTXSID10438352-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-{2-hydroxy-3-[2-(prop-2-en-1-yloxy)phenoxy]propyl}(propan-2-yl)amineoxprenololo(2-hydroxy-3-(2-(prop-2-en-1-yloxy)phenoxy)propyl)(propan-2-yl)amineTrasicor, Slow
Show more names
TevacorOxenalolAids001596Aids-001596Oxprenolol-d7oxprenolol USP/EP/BPCoretal (hydrochloride)1-(2-allyloxyphenoxy)-3-isopropylaminopropan-2-ol
RefChem:857811DTXCID9023835C07AA02229-257-9245-359-6dl-Oxprenolol(+-)-OxprenololOsprenololo [DCIT]

Database identifiers

CAS
6452-71-7
PubChem CID
4631
DTXSID
DTXSID1043835

Properties

Computed structural propertiesFilling in

XLogP
2.1
Topological polar surface area
50.7 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
9
Heavy atoms
19
Formal charge
0
Complexity
246

Experimental & physicochemical properties

Chemical ClassesOther Uses -> Pharmaceuticals
Drugs · 2 items

Pharmaceuticals

Pharmaceuticals -> Antihypertensives

LogP · 2 items

2.10

2.25

Solubility6.80e-01 g/L
Human DrugsPharmaceuticals
Physical DescriptionSolid
Dissociation Constants9.57
Collision Cross Section161.7 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Physicochemical properties

Melting point
78 · 78-80°

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Regulatory Information2-Propanol, 1-(1-methylethyl)amino-3-2-(2-propenyloxy)phenoxy-: Does not have an individual approval but may be used under an appropriate group standard
Hazards SummaryAllergic contact dermatitis reported in a pharmaceutical worker; [Kanerva, p. 1822] See Propranolol.
Hazard Classes and CategoriesAcute Tox. 3 (100%)

Toxicology

Adverse EffectsSkin Sensitizer - An agent that can induce an allergic reaction in the skin.

Safety data

Signal word
Danger
Symbol(GHS)
GHS06
Hazard statements
H331-H311-H301
Precautionary statements
P280-P302+P352-P312-P322-P361-P363-P405-P501-P261-P271-P304+P340-P311-P321-P403+P233-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501

Chemistry & industry

Pharmacology

ATC Code · 2 items

C - Cardiovascular system

QC - Cardiovascular system

Pharmacodynamics · 1 item

Oxprenolol is a non-selective beta blocker with some intrinsic sympathomimetic activity. Oxprenolol is a lipophilic molecule and hence, it is able to cross the blood-brain barrier. As such, it is associated with a higher incidence of CNS-related side effects than hydrophilic ligands such as atenolol, sotalol and nadolol. Oxprenolol is an potent beta-blocker and should not be administered to asthmatics because it can cause irreversible airway failure and inflammation.

Mechanism of Action · 1 item

Like other beta-adrenergic antagonists, oxprenolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, oxprenolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, oxprenolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Oxprenolol therefore inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively.

Biological Half-Life1-2 hours
Metabolism/Metabolites · 2 items

Hepatic.

Oxoprenolol has known human metabolites that include Oxprenolol glucuronide.

MeSH Pharmacological Classification · 6 items

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Related reactions

1 records
New reaction record
HRID 328893 reaction equation
HRID 328893As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEMBL
CHEMBL546
ChEBI
CHEBI:91704
UNII
519MXN9YZR
EC Number
229-257-9
Nikkaji
J318.375K、J8.410G
Boiling point
408.57 °C · 408.57°C (rough estimate)
Density
1.0479 · 1.0479 (rough estimate)
refractive index
1.5 · 1.5000 (estimate)
solubility
Dichloromethane (Slightly), Methanol (Slightly)
form
Solid
pka
13.89 · 13.89±0.20(Predicted)
color
White to Off-White
Stability
Stable under recommended storage conditions., Stable Under Recommended Storage C
FDA UNII
519 MXN9YZR · 519MXN9YZR
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
331 · H331-H311-H301
Precautionary statements
280 · P280-P302+P352-P312-P322-P361-P363-P405-P501-P261-P271-P304+P340-P311-P321-P403+P233-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and ExcretionOral bioavailability is 20-70%.
Cellular LocationsMembrane
Metabolite PathwaysOxprenolol Action Pathway

Uses & manufacturing

Uses · 2 items

Used as a beta-blocking agent; [Kanerva, p. 1822]

Use (kg; approx.) in Germany (2009): >50

Use ClassificationPharmaceuticals
Applications · 3 items

DescriptionOxprenolol induced contact dermatitis in a worker at a pharmaceutical plant, in the division for drug synthesis. Epichlorhydrin was also used for the production of both propranolol and oxprenolol.

UsesOxprenolol is a free base of Oxprenolol Hydrochloride(O870500) which is a β-Adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic.

UsesVasodilator(coronary).

Upstream & downstream products

Upstream raw materials

IsopropylamineEpichlorohydrin

Additional notes

DefinitionChEBI: 1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)-2-propanol is an aromatic ether.